Diagnostic value of WT1 in neuroepithelial tumours

Neuropathology and Applied Neurobiology

Volumn 35, Issue 1, 2009, Pages 69-81

  Schittenhelm, J ^a   Beschorner, R ^a   Simon, P ^b   Tabatabai, G ^a   Herrmann, C ^a   Schlaszus, H ^a   Capper, D ^a   Weller, M ^a   Meyermann, R ^a   Mittelbronn, M ^a,c  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Astrocytoma; Central nervous system; Ependymoma; Oligodendroglioma; WT1

Indexed keywords

MESSENGER RNA; WT1 PROTEIN;

ADULT; ARTICLE; ASTROCYTOMA; CANCER STAGING; CENTRAL NERVOUS SYSTEM; CLINICAL ARTICLE; CONTROLLED STUDY; EPENDYMOMA; FEMALE; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NEUROEPITHELIOMA; OLIGODENDROGLIOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; WORLD HEALTH ORGANIZATION;

ADULT; BLOTTING, WESTERN; BRAIN; BRAIN NEOPLASMS; CHILD; ENDOTHELIAL CELLS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LOGISTIC MODELS; MALE; MIDDLE AGED; NEOPLASMS, NEUROEPITHELIAL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TISSUE ARRAY ANALYSIS; WT1 PROTEINS; YOUNG ADULT;

EID: 58849123732     PISSN: 03051846     EISSN: 13652990     Source Type: Journal    
DOI: 10.1111/j.1365-2990.2008.00957.x     Document Type: Article

References (48)

1. Pritchard-Jones K. The Wilms tumour gene, WT1, in normal and abnormal nephrogenesis. Pediatr Nephrol 1999 13 : 620 5
2. Wilms M. Die Mischgeschwülste der Niere. Leipzig : Arthur Georgi. 1899, 1 90
3. Madden SL, Cook DM, Morris JF, Gashler A, Sukhatme VP, Rauscher FJ III. Transcriptional repression mediated by the WT1 Wilms tumor gene product. Science 1991 253 : 1550 3
4. Menke AL, van der Eb AJ, Jochemsen AG. The Wilms' tumor 1 gene: oncogene or tumor suppressor gene? Int Rev Cytol 1998 181 : 151 212
5. Hosono S, Gross I, English MA, Hajra KM, Fearon ER, Licht JD. E-cadherin is a WT1 target gene. J Biol Chem 2000 275 : 10943 53
6. Werner H, Re GG, Drummond IA, Sukhatme VP, Rauscher FJ 3rd, Sens DA, Garvin AJ, LeRoith D, Roberts CT Jr. Increased expression of the insulin-like growth factor I receptor gene, IGF1R, in Wilms tumour is correlated with modulation of IGF1R promoter activity by the WT1 Wilms tumour gene product. Proc Natl Acad Sci USA 1993 90 : 5828 32
7. Nichols KE, Re GG, Yan YX, Garvin AJ, Haber DA. WT1 induces expression of insulin-like growth factor 2 in Wilms' tumour cells. Cancer Res 1995 55 : 4540 3
8. Johnstone RW, See RH, Sells SF, Wang J, Muthukkumar S, Englert C, Haber DA, Licht JD, Sugrue SP, Roberts T, Rangnekar VM, Shi Y. A novel repressor, par-4, modulates transcription and growth suppression functions of the Wilms' tumor suppressor WT1. Mol Cell Biol 1996 16 : 6945 56
9. Maheswaran S, Park S, Bernard A, Morris JF, Rauscher FJ 3rd, Hill DE, Haber DA. Physical and functional interaction between WT1 and p53 proteins. Proc Natl Acad Sci USA 1993 90 : 100 4
10. Haber DA, Englert C, Maheswaran S. Functional properties of WT1. Med Pediatr Oncol 1996 27 : 453 5
11. Hewitt SM, Hamada S, McDonnell TJ, Rauscher FJ 3rd, Saunders GF. Regulation of the proto-oncogenes bcl-2 and c-myc by the Wilms' tumor suppressor gene WT1. Cancer Res 1995 55 : 5386 9
12. Inoue K, Sugiyama H, Ogawa H, Nakagawa M, Yamagami T, Miwa H, Kita K, Hiraoka A, Masaoka T, Nasu K, Kyo T, Doohu K, Nakauchi H, Ishidate T, Akiyama T, Kishimoto T. WT1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia. Blood 1994 84 : 3071 9
13. Hill DA, Pfeifer JD, Marley EF, Dehner LP, Humphrey PA, Zhu X, Swanson PE. WT1 staining reliably differentiates desmoplastic small round cell tumour from Ewing sarcoma/primitive neuroectodermal tumour. An immunohistochemical and molecular diagnostic study. Am J Clin Pathol 2000 114 : 345 53
14. Amini Nik S, Hohenstein P, Jadidizadeh A, Van Dam K, Bastidas A, Berry RL, Patek CE, Van der Schueren B, Cassiman JJ, Tejpar S. Upregulation of Wilms' tumour gene 1 (WT1) in desmoid tumours. Int J Cancer 2005 114 : 202 8
15. Carpentieri DF, Nichols K, Chou PM, Matthews M, Pawel B, Huff D. The expression of WT1 in the differentiation of rhabdomyosarcoma from other pediatric small round blue cell tumours. Mod Pathol 2002 15 : 1080 6
16. Rodeck U, Bossler A, Kari C, Humphreys CW, Gyorfi T, Maurer J, Thiel E, Menssen HD. Expression of the wt1 Wilms' tumour gene by normal and malignant human melanocytes. Int J Cancer 1994 59 : 78 82
17. Kumar-Singh S, Segers K, Rodeck U, Backhovens H, Bogers J, Weyler J, Van Broeckhoven C, Van Marck E. WT1 mutation in malignant mesothelioma and WT1 immunoreactivity in relation to p53 and growth factor receptor expression, cell-type transition, and prognosis. J Pathol 1997 181 : 67 74
18. Loeb DM, Evron E, Patel CB, Sharma PM, Niranjan B, Buluwela L, Weitzman SA, Korz D, Sukumar S. Wilms' tumour suppressor gene (WT1) is expressed in primary breast tumours despite tumour-specific promoter methylation. Cancer Res 2001 61 : 921 5
19. Wagner KD, Wagner N, Vidal VP, Schley G, Wilhelm D, Schedl A, Englert C, Scholz H. The Wilms' tumour gene Wt1 is required for normal development of the retina. EMBO J 2002 21 : 1398 405
20. Mundlos S, Pelletier J, Darveau A, Bachmann M, Winterpacht A, Zabel B. Nuclear localization of the protein encoded by the Wilms' tumour gene WT1 in embryonic and adult tissues. Development 1993 119 : 1329 41
21. Armstrong JF, Pritchard-Jones K, Bickmore WA, Hastie ND, Bard JB. The expression of the Wilms' tumour gene, WT1, in the developing mammalian embryo. Mech Dev 1993 40 : 85 97
22. Menssen HD, Bertelmann E, Bartelt S, Schmidt RA, Pecher G, Schramm K, Thiel E. Wilms' tumour gene (WT1) expression in lung cancer, colon cancer and glioblastoma cell lines compared to freshly isolated tumour specimens. J Cancer Res Clin Oncol 2000 126 : 226 32
23. Dennis SL, Manji SS, Carrington DP, Scarcella DL, Ashley DM, Smith PJ, Algar EM. Expression and mutation analysis of the Wilms' tumour 1 gene in human neural tumours. Int J Cancer 2002 97 : 713 15
24. Oji Y, Suzuki T, Nakano Y, Maruno M, Nakatsuka S, Jomgeow T, Abeno S, Tatsumi N, Yokota A, Aoyagi S, Nakazawa T, Ito K, Kanato K, Shirakata T, Nishida S, Hosen N, Kawakami M, Tsuboi A, Oka Y, Aozasa K, Yoshimine T, Sugiyama H. Overexpression of the Wilms' tumour gene W T1 in primary astrocytic tumours. Cancer Sci 2004 95 : 822 7
25. Mittelbronn M, Capper D, Bunz B, Dietz K, Goeppert B, Ajaaj R, Tabatabai G, Stubenvoll F, Schlaszus H, Merseburger AS, Becker R, Freudenstein D, Wick W, Weller M, Meyermann R, Simon P. De novo erythropoietin receptor (EPO-R) expression in human neoplastic glial cells decreases with grade of malignancy but is favourably associated with patient survival. Neuropathol Appl Neurobiol 2007 33 : 299 307
26. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK. Pathology & Genetics: WHO classification of Tumours of the Central Nervous System. Lyon : International Agency for Research on Cancer Press, 2007
27. Clark AJ, Dos SW, McCready J, Chen MY, Van Meter TE, Ware JL, Wolber SB, Fillmore H, Broaddus WC. Wilms tumor 1 expression in malignant gliomas and correlation of +KTS isoforms with p53 status. J Neurosurg 2007 107 : 586 92
28. Nakahara Y, Okamoto H, Mineta T, Tabuchi K. Expression of the Wilms' tumour gene product WT1 in glioblastomas and medulloblastomas. Brain Tumour Pathol 2004 21 : 113 16
29. Hashiba T, Izumoto S, Kagawa N, Suzuki T, Hashimoto N, Maruno M, Yoshimine T. Expression of WT1 protein and correlation with cellular proliferation in glial tumours. Neurol Med Chir 2007 47 : 165 70
30. Burger PC, Scheithauer BW, Vogel FS. Surgical Pathology of the Nervous System and its Coverings, 4th edn. Philadelphia, PA : Elsevier, 2002
31. Blümcke I, Becker AJ, Normann S, Hans V, Riederer BM, Krajewski S, Wiestler OD, Reifenberger G. Distinct expression pattern of microtubule- associated protein-2 in human oligodendrogliomas and glial precursor cells. J Neuropathol Exp Neurol 2001 60 : 984 93
32. Marie Y, Sanson M, Mokhtari K, Leuraud P, Kujas M, Delattre JY, Poirier J, Zalc B, Hoang-Xuan K. OLIG2 as a specific marker of oligodendroglial tumour cells. Lancet 2001 358 : 298 300
33. Ligon KL, Alberta JA, Kho AT, Weiss J, Kwaan MR, Nutt CL, Louis DN, Stiles CD, Rowitch DH. The oligodendroglial lineage marker OLIG2 is universally expressed in diffuse gliomas. J Neuropathol Exp Neurol 2004 63 : 499 509
34. Kros JM, Stefanko SZ, de Jong AA, van Vroonhoven CC, van der Heul RO, van der Kwast TH. Ultrastructural and immunohistochemical segregation of gemistocytic subsets. Hum Pathol 1991 22 : 33 40
35. Scharnhorst V, Kranenburg O, van der Eb AJ, Jochemsen AG. Differential regulation of the Wilms' tumor gene, WT1, during differentiation of embryonal carcinoma and embryonic stem cells. Cell Growth Differ 1997 8 : 133 43
36. Ellisen LW. Regulation of gene expression by WT1 in development and tumourigenesis. Int J Hematol 2002 76 : 110 16
37. Silberstein GB, Van Horn K, Strickland P, Roberts CT Jr, Daniel CW. Altered expression of the WT1 wilms tumour suppressor gene in human breast cancer. Proc Natl Acad Sci USA 1997 94 : 8132 7
38. Coosemans A, Nik SA, Caluwaerts S, Lambin S, Verbist G, Van Bree R, Schelfhout V, de Jonge E, Dalle I, Jacomen G, Cassiman JJ, Moerman P, Vergote I, Amant F. Upregulation of Wilms' tumour gene 1 (WT1) in uterine sarcomas. Eur J Cancer 2007 43 : 1630 7
39. Oji Y, Yamamoto H, Nomura M, Nakano Y, Ikeba A, Nakatsuka S, Abeno S, Kiyotoh E, Jomgeow T, Sekimoto M, Nezu R, Yoshikawa Y, Inoue Y, Hosen N, Kawakami M, Tsuboi A, Oka Y, Ogawa H, Souda S, Aozasa K, Monden M, Sugiyama H. Overexpression of the Wilms' tumour gene WT1 in colorectal adenocarcinoma. Cancer Sci 2003 94 : 712 17
40. Sumathi VP, Al-Hussaini M, Connolly LE, Fullerton L, McCluggage WG. Endometrial stromal neoplasms are immunoreactive with WT1 antibody. Int J Gynecol Pathol 2004 23 : 241 7
41. Nakatsuka S, Oji Y, Horiuchi T, Kanda T, Kitagawa M, Takeuchi T, Kawano K, Kuwae Y, Yamauchi A, Okumura M, Kitamura Y, Oka Y, Kawase I, Sugiyama H, Aozasa K. Immunohistochemical detection of WT1 protein in a variety of cancer cells. Mod Pathol 2006 19 : 804 14
42. Niksic M, Slight J, Sanford JR, Caceres JF, Hastie ND. The Wilms' tumour protein (WT1) shuttles between nucleus and cytoplasm and is present in functional polysomes. Hum Mol Genet 2004 13 : 463 71
43. Graham K, Li W, Williams BR, Fraizer G. Vascular endothelial growth factor (VEGF) is suppressed in WT1-transfected LNCaP cells. Gene Expr 2006 13 : 1 14
44. Hanson J, Gorman J, Reese J, Fraizer G. Regulation of vascular endothelial growth factor, VEGF, gene promoter by the tumor suppressor, WT1. Front Biosci 2007 12 : 2279 90
45. Ohminami H, Yasukawa M, Fujita S. HLA class I-restricted lysis of leukemia cells by a CD8(+) cytotoxic T-lymphocyte clone specific for WT1 peptide. Blood 2000 95 : 286 93
46. Makita M, Hiraki A, Azuma T, Tsuboi A, Oka Y, Sugiyama H, Fujita S, Tanimoto M, Harada M, Yasukawa M. Antilung cancer effect of WT1-specific cytotoxic T lymphocytes. Clin Cancer Res 2002 8 : 2626 31
47. Oka Y, Tsuboi A, Taguchi T, Osaki T, Kyo T, Nakajima H, Elisseeva OA, Oji Y, Kawakami M, Ikegame K, Hosen N, Yoshihara S, Wu F, Fujiki F, Murakami M, Masuda T, Nishida S, Shirakata T, Nakatsuka S, Sasaki A, Udaka K, Dohy H, Aozasa K, Noguchi S, Kawase I, Sugiyama H. Induction of WT1 (Wilms' tumour gene) -specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression. Proc Natl Acad Sci USA 2004 101 : 13885 90
48. Asemissen AM, Keilholz U, Tenzer S, Muller M, Walter S, Stevanovic S, Schild H, Letsch A, Thiel E, Rammensee HG, Scheibenbogen C. Identification of a highly immunogenic HLA-A*01-binding T cell epitope of WT1. Clin Cancer Res 2006 12 : 7476 82